Humanigen, Inc.

ACTIVE

830 Morris Tpke FL 4, 加利福尼亚州圣马特奥县, California, United Stateswww.humanigen.comPublic11–50 employeesEstablished: 2001-01-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2001

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

50.0%

Phase 2

37.5%

Phase 3

12.5%

Trial Status Distribution

Completed

62.5%

Suspended

12.5%

Terminated

12.5%

Unknown

12.5%

Clinical Trials

Trials sponsored by this organization (8)

Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19

Phase 3

Unknown

interventional

May 2020520 participants

Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML)

Phase 1

Completed

interventional

Jul 201615 participants

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Phase 2

Completed

interventional

Dec 2012182 participants

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Phase 2

Completed

interventional

Jul 2012160 participants

Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)

Phase 1

Suspended

interventional

Sep 2010120 participants

Study of KB003 In Biologics-Inadequate Rheumatoid Arthritis

Phase 2

Terminated

interventional

Jan 20109 participants

Pilot Trial of KB001 in Mechanically-Ventilated Patients Colonized With Pseudomonas Aeruginosa

Phase 1

Completed

interventional

Apr 200836 participants

Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas Aeruginosa

Phase 1

Completed

interventional

Mar 200827 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations